| Mouse granzyme K has pro-inflammatory potential LT Joeckel, R Wallich, P Martin, D Sanchez-Martinez, FC Weber, ... Cell Death & Differentiation 18 (7), 1112-1119, 2011 | 109 | 2011 |
| Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ... Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019 | 97 | 2019 |
| Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells D De Miguel, G Basáñez, D Sanchez, PG Malo, I Marzo, L Larrad, J Naval, ... Molecular pharmaceutics 10 (3), 893-904, 2013 | 89 | 2013 |
| Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors D Sanchez-Martinez, N Allende-Vega, S Orecchioni, G Talarico, ... Theranostics 8 (14), 3856, 2018 | 60 | 2018 |
| Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression PM Lanuza, A Vigueras, S Olivan, AC Prats, S Costas, G Llamazares, ... Oncoimmunology 7 (4), e1395123, 2018 | 53 | 2018 |
| Human NK cells activated by EBV+ lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells D Sánchez-Martínez, G Azaceta, A Muntasell, N Aguiló, D Núñez, ... Oncoimmunology 4 (3), e991613, 2015 | 51 | 2015 |
| All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity D Sanchez-Martínez, E Krzywinska, MG Rathore, A Saumet, A Cornillon, ... The international journal of biochemistry & cell biology 49, 42-52, 2014 | 51 | 2014 |
| 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo ML Baroni, DS Martinez, FG Aguera, HR Ho, M Castella, SR Zanetti, ... Journal for immunotherapy of cancer 8 (1), 2020 | 42 | 2020 |
| CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity C Bueno, T Velasco-Hernandez, F Gutiérrez-Agüera, SR Zanetti, ... Leukemia 33 (8), 2090-2125, 2019 | 38 | 2019 |
| NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia B Lopez-Millan, D Sanchéz-Martínez, H Roca-Ho, F Gutiérrez-Agüera, ... Leukemia 33 (7), 1557-1569, 2019 | 38 | 2019 |
| Activated allogeneic NK cells preferentially kill poor prognosis B-cell chronic lymphocytic leukemia cells D Sánchez-Martínez, PM Lanuza, N Gómez, A Muntasell, E Cisneros, ... Frontiers in immunology 7, 454, 2016 | 38 | 2016 |
| Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance T Calvo, C Reina-Ortiz, D Giraldos, M Gascón, D Woods, J Asenjo, ... Scientific Reports 10 (1), 19398, 2020 | 30 | 2020 |
| A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera, VM Díaz, ... Molecular Therapy 30 (2), 550-563, 2022 | 28 | 2022 |
| Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia. D Sanchez-Martinez, N Tirado, S Mensurado, A Martínez-Moreno, ... Journal for Immunotherapy of Cancer 10 (9), e005400-e005400, 2022 | 22 | 2022 |
| A functional analysis on the interspecies interaction between mouse LFA-1 and human intercellular adhesion molecule-1 at the cell level D Núñez, L Comas, PM Lanuza, D Sánchez-Martinez, ... Frontiers in immunology 8, 1817, 2017 | 13 | 2017 |
| Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope T Velasco-Hernandez, SR Zanetti, H Roca-Ho, F Gutierrez-Aguera, ... Journal for immunotherapy of cancer 8 (2), 2020 | 11 | 2020 |
| Enforced sialyl‐Lewis‐X (sLeX) display in E‐selectin ligands by exofucosylation is dispensable for CD19‐CAR T‐cell activity and bone marrow homing D Sánchez‐Martínez, F Gutiérrez‐Agüera, P Romecin, M Vinyoles, ... Clinical and Translational Medicine 11 (2), e280, 2021 | 10 | 2021 |
| Recombinant production of human ICAM-1 chimeras by single step on column refolding and purification D Núñez, MP Domingo, D Sánchez-Martínez, V Cebolla, A Chiou, ... Process biochemistry 48 (4), 708-715, 2013 | 9 | 2013 |
| Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers A Jiménez-Reinoso, N Tirado, A Martinez-Moreno, VM Díaz, ... Journal for Immunotherapy of Cancer 10 (12), 2022 | 5 | 2022 |
| CD84: A Novel Target for CAR T-Cell Therapy for Acute Myeloid Leukemia L Pérez-Amill, M Armand-Ugon, S Peña, M Val Casals, C Santos, ... Blood 140 (Supplement 1), 7379-7381, 2022 | 4 | 2022 |
